About Providence Therapeutics
Where Hope and Science Intersect
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Calgary, Alberta
- Founded
- 2015
- Company type
- Privately Held
Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development.
The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENTā¢ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providenceās mRNA and INTENTā¢ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary INTENTā¢ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery.
Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com
Specialties
- mRNA therapeutics
- personalized vaccines
- cancer vaccines
- lipid nanoparticles
- COVID-19 Vaccine
- and biotech
Company locations
120, 8832 Blackfoot Trail, Calgary, Alberta T2J 3J1, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Health Care
- Wellness
- Biotechnology
- Therapeutics
On LinkedIn
- Followers
- 7,501
- People linked to this company
- 58
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
5,594,087 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.